CorMedix (CRMD) PT Raised to $22 at RBC Capital Oct 21, 2025 09:09AM
CorMedix (CRMD) PT Lowered to $21 at RBC Capital, 'we would be buyers' Oct 20, 2025 05:08AM
CorMedix to acquire Melinta Therapeutics for $300 million Aug 7, 2025 07:00AM
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings Aug 7, 2025 07:00AM
CorMedix (CRMD) Prices $85M Offering Jun 27, 2025 08:00AM


Jun 27, 2025 08:00AM CorMedix Inc. Announces Pricing of Public Offering of Common Stock
Jun 26, 2025 04:01PM CorMedix (CRMD) announces $85 million public offering
Jun 26, 2025 04:01PM CorMedix Inc. Announces Proposed Public Offering of Common Stock
Jun 20, 2025 10:13AM CorMedix (CRMD) PT Raised to $17 at RBC Capital; 'Outpatient Strength Likely to Continue in 2H'
May 15, 2025 08:30AM CorMedix Inc. to Participate in the RBC Global Healthcare Conference
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Dec 19, 2024 10:56AM CorMedix (CRMD) PT Raised to $12 as RBC Capital Sees a 'Supportive Setup for DefenCath into '25'
May 10, 2024 08:30AM CorMedix Inc. to Participate in Two Upcoming Investor Conferences
Mar 13, 2024 06:21AM CorMedix (CRMD) PT Lowered to $9 at RBC Capital
Jun 29, 2023 05:41AM CorMedix (CRMD) Prices $40M Share and Warrant Offering at $4/sh
Jun 28, 2023 10:57PM CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants
Jun 28, 2023 04:08PM CorMedix (CRMD) Announces Proposed Stock and Warrant Offering
Jun 28, 2023 04:07PM CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Mar 3, 2016 10:55AM Notable Analyst Rating Changes 3/3: (DIS) (INTC) (BWLD) Upgraded; (BA) (NDLS) (AA) Downgraded
Jul 24, 2014 10:43AM Notable Analyst Rating Changes 07/24: (RKUS) (UIS) (SEIC) Upgraded; (ANGI) (QCOM) (BA) Downgraded